Apr 14
|
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
|
Apr 10
|
Grifols Plans First Bond Sale Since Short Seller Attack
|
Apr 4
|
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
|
Mar 21
|
Grifols’ Financials Have No Big Errors, Spanish Regulator Says
|
Mar 8
|
Health Care Roundup: Market Talk
|
Mar 8
|
UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus
|
Mar 6
|
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
|
Jan 18
|
ECB Asks Banks for Details About Exposure to Spain’s Grifols
|
Jan 17
|
Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos
|
Jan 15
|
Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks
|
Jan 14
|
Grifols Says Haier Has Offered Reassurance on China Deal
|
Jan 14
|
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
|
Jan 12
|
Grifols shares suffer worst week on record after short-seller report
|
Jan 12
|
Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult
|
Jan 11
|
Gotham Allegations ‘False,’ Grifols CEO Tells Investors
|
Jan 11
|
Grifols sees China stake sale going ahead despite Gotham City report
|
Jan 11
|
Grifols Faces Scrutiny of Billionaire Family’s Control
|
Jan 10
|
Gotham Slashes Grifols Short Position on Same Day as Selloff
|
Jan 10
|
Short Seller Attack Adds to Billionaire Grifols Dynasty Pain
|
Jan 10
|
Spain's Grifols to sue short-seller over critical report, shares jump
|